Oncology
Specific bacteria in combination with a hydrogel containing silver nanoparticles can reduce tumor growth in mice with a cancer of the oral cavity. A new study published in Nature Biomedical…
The mouth microbiota may be used as a potential biomarker and target for the diagnosis and treatment of colorectal cancer. A new study pulished in Cell Reports claims.
Some individuals with advanced prostate cancer develop resistance to ADT, which promotes the expansion of specific gut bacteria that can synthesize androgens.
The findings of a recent study published in Science Advances suggest that a high-salt diet modulates the gut microbiota in ways that boost tumor immunity.
Chemotherapy treatment and intestinal diseases can alter the process of programmed cell death, which can lead to gastrointestinal tract's infections.
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
Probiotics such as Lactobacillus and Bifidobacterium can activate a person’s immune system and improve the response to some anti-cancer therapies.
TCGA allows to explore the role of tissue-resident microbiota in various cancer types and identifying predictive microbial biomarkers.
Decreased microbial diversity and increased abundance of Firmicutes phylum in the respiratory tract may be associated with an increased risk of lung cancer.
Researches suggest that Lachnospiraceae and Enterococcaceae, as well as bacterial metabolites such as propionate can contribute to radioprotection.
